Innocare

Innocare

Verified
A Chinese biopharmaceutical company that develops treatment for cancer and autoimmune diseases.

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$369m (Public information from May 2024)
Beijing China (HQ)
No columns specified